Monopar Therapeutics Inc.
26.05
1.07 (4.28%)
At close: Jan 15, 2025, 3:59 PM
26.91
3.31%
After-hours Jan 15, 2025, 04:00 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15
Net Income -8.40M -10.52M -9.10M -6.30M -4.22M -3.23M -16.55M -1.19M -687.31K
Depreciation & Amortization n/a n/a n/a n/a n/a n/a n/a n/a n/a
Stock-Based Compensation 1.90M 1.64M 1.47M 1.32M 1.01M 529.33K 305.20K n/a n/a
Other Working Capital -20.41K 167.52K -86.20K -3.79K -47.51K -275.84K -126.78K 298.00 -22.86K
Other Non-Cash Items n/a 162.96K 1.06M -122.40K 767.64K 441.65K 13.50M 9.33K -73.84K
Deferred Income Tax n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital -1.35M 1.65M 317.77K 443.81K 196.02K -188.16K 120.58K -9.04K 50.98K
Operating Cash Flow -7.86M -7.23M -7.32M -4.66M -3.02M -2.89M -2.63M -1.19M -636.33K
Capital Expenditures n/a n/a n/a n/a n/a n/a n/a n/a n/a
Acquisitions n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments -7.88M -4.92M n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments 12.81M n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies n/a -4.92K n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow 4.93M -4.92M n/a n/a n/a n/a n/a n/a n/a
Debt Repayment n/a n/a n/a 122.40K n/a n/a n/a n/a n/a
Common Stock Repurchased n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies -46.97K -76.46K -45.77K -115.57K -874.81K -206.27K 4.83M 1.26M 3.44M
Financial Cash Flow 2.03M 32.87K 10.88M 8.18M 9.35M -206.27K 9.54M 1.26M 3.44M
Net Cash Flow -920.11K -12.12M 3.57M 3.52M 6.32M -2.89M 6.91M 67.87K 2.81M
Free Cash Flow -7.86M -7.23M -7.32M -4.66M -3.02M -2.89M -2.63M -1.19M -636.33K

Create Price Alert on MNPR

Your price alert will notify you when the stock price is above 26.05.

Add to Watchlist